Sirico, M.; Bernocchi, O.; Sobhani, N.; Giudici, F.; Corona, S.P.; Vernieri, C.; Nichetti, F.; Cappelletti, M.R.; Milani, M.; Strina, C.;
et al. Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer. Cancers 2020, 12, 3314.
https://doi.org/10.3390/cancers12113314
AMA Style
Sirico M, Bernocchi O, Sobhani N, Giudici F, Corona SP, Vernieri C, Nichetti F, Cappelletti MR, Milani M, Strina C,
et al. Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer. Cancers. 2020; 12(11):3314.
https://doi.org/10.3390/cancers12113314
Chicago/Turabian Style
Sirico, Marianna, Ottavia Bernocchi, Navid Sobhani, Fabiola Giudici, Silvia P. Corona, Claudio Vernieri, Federico Nichetti, Maria Rosa Cappelletti, Manuela Milani, Carla Strina,
and et al. 2020. "Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer" Cancers 12, no. 11: 3314.
https://doi.org/10.3390/cancers12113314
APA Style
Sirico, M., Bernocchi, O., Sobhani, N., Giudici, F., Corona, S. P., Vernieri, C., Nichetti, F., Cappelletti, M. R., Milani, M., Strina, C., Cervoni, V., Barbieri, G., Ziglioli, N., Dester, M., Bianchi, G. V., De Braud, F., & Generali, D.
(2020). Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer. Cancers, 12(11), 3314.
https://doi.org/10.3390/cancers12113314
